CASP3 and breast fibrocystic disease: In the EC-CFUs from healthy controls and benign breast disease patients, higher levels of caspase 3 activities were demonstrated after incubation of TNF-α at 1 and 10 pg/ml compared to those who received no TNF-α treatment.